Royal Bank of Canada Issues Pessimistic Forecast for Viracta Therapeutics (NASDAQ:VIRX) Stock Price
Viracta Therapeutics (NASDAQ:VIRX – Get Free Report) had its price objective decreased by stock analysts at Royal Bank of Canada from $4.00 to $2.00 in a report issued on Thursday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Separately, Leerink Partners lowered shares of Viracta Therapeutics from an “outperform” rating to a […]
Barclays Issues Pessimistic Forecast for Spirit Airlines (NYSE:SAVE) Stock Price
Spirit Airlines (NYSE:SAVE – Get Free Report) had its price target decreased by investment analysts at Barclays from $3.00 to $0.50 in a report issued on Thursday,Benzinga reports. The brokerage presently has an “underweight” rating on the stock. Barclays‘s price target would indicate a potential downside of 63.51% from the stock’s current price. A number […]
Piper Sandler Issues Pessimistic Forecast for Immunome (NASDAQ:IMNM) Stock Price
Immunome (NASDAQ:IMNM – Get Free Report) had its target price dropped by stock analysts at Piper Sandler from $23.00 to $21.00 in a report issued on Thursday,Benzinga reports. The firm presently has an “overweight” rating on the stock. Piper Sandler’s target price points to a potential upside of 81.19% from the stock’s previous close. IMNM […]
Bank of America Issues Pessimistic Forecast for Progyny (NASDAQ:PGNY) Stock Price
Progyny (NASDAQ:PGNY – Get Free Report) had its price target decreased by Bank of America from $22.00 to $21.00 in a research note issued to investors on Wednesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Bank of America‘s target price suggests a potential upside of 47.89% from the company’s current price. […]
Citigroup Issues Pessimistic Forecast for United Parcel Service (NYSE:UPS) Stock Price
United Parcel Service (NYSE:UPS – Get Free Report) had its price target reduced by equities research analysts at Citigroup from $163.00 to $158.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the transportation company’s stock. Citigroup’s price objective would indicate a potential upside […]
BMO Capital Markets Issues Pessimistic Forecast for AbbVie (NYSE:ABBV) Stock Price
AbbVie (NYSE:ABBV – Get Free Report) had its price objective reduced by analysts at BMO Capital Markets from $228.00 to $208.00 in a research note issued on Tuesday,Benzinga reports. The firm presently has an “outperform” rating on the stock. BMO Capital Markets’ price objective would indicate a potential upside of 19.54% from the company’s current […]
UBS Group Issues Pessimistic Forecast for ODP (NASDAQ:ODP) Stock Price
ODP (NASDAQ:ODP – Free Report) had its price target cut by UBS Group from $30.00 to $28.00 in a report issued on Thursday,Benzinga reports. They currently have a neutral rating on the specialty retailer’s stock. Separately, StockNews.com lowered ODP from a “buy” rating to a “hold” rating in a research report on Thursday, August 8th. […]
Needham & Company LLC Issues Pessimistic Forecast for Vacasa (NASDAQ:VCSA) Stock Price
Vacasa (NASDAQ:VCSA – Get Free Report) had its price objective cut by research analysts at Needham & Company LLC from $5.00 to $3.25 in a report issued on Monday,Benzinga reports. The firm currently has a “buy” rating on the stock. Needham & Company LLC’s price objective points to a potential upside of 17.33% from the […]
B. Riley Issues Pessimistic Forecast for e.l.f. Beauty (NYSE:ELF) Stock Price
e.l.f. Beauty (NYSE:ELF – Free Report) had its price objective reduced by B. Riley from $175.00 to $150.00 in a report issued on Thursday,Benzinga reports. B. Riley currently has a buy rating on the stock. Several other research firms have also recently weighed in on ELF. Morgan Stanley lowered their price target on shares of […]
Citigroup Issues Pessimistic Forecast for Williams-Sonoma (NYSE:WSM) Stock Price
Williams-Sonoma (NYSE:WSM – Get Free Report) had its price target cut by stock analysts at Citigroup from $140.00 to $134.00 in a research note issued to investors on Friday,Benzinga reports. The firm currently has a “neutral” rating on the specialty retailer’s stock. Citigroup’s price objective would suggest a potential upside of 3.24% from the company’s […]
JPMorgan Chase & Co. Issues Pessimistic Forecast for First Quantum Minerals (TSE:FM) Stock Price
First Quantum Minerals (TSE:FM – Get Free Report) had its price target lowered by equities research analysts at JPMorgan Chase & Co. from C$20.00 to C$18.00 in a report issued on Friday,BayStreet.CA reports. JPMorgan Chase & Co.‘s target price suggests a potential downside of 5.71% from the stock’s previous close. Other research analysts have also […]
B. Riley Issues Positive Forecast for Century Aluminum (NASDAQ:CENX) Stock Price
Century Aluminum (NASDAQ:CENX – Free Report) had its price objective raised by B. Riley from $22.00 to $24.00 in a research report report published on Tuesday morning,Benzinga reports. The firm currently has a buy rating on the industrial products company’s stock. Several other equities research analysts also recently weighed in on the company. BMO Capital […]
B. Riley Issues Pessimistic Forecast for Full House Resorts (NASDAQ:FLL) Stock Price
Full House Resorts (NASDAQ:FLL – Get Free Report) had its price target decreased by equities research analysts at B. Riley from $9.00 to $8.00 in a research note issued to investors on Thursday,Benzinga reports. The firm currently has a “buy” rating on the stock. B. Riley’s target price would indicate a potential upside of 59.36% […]
DA Davidson Issues Pessimistic Forecast for e.l.f. Beauty (NYSE:ELF) Stock Price
e.l.f. Beauty (NYSE:ELF – Get Free Report) had its price target lowered by analysts at DA Davidson from $223.00 to $170.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The firm currently has a “buy” rating on the stock. DA Davidson’s price target indicates a potential upside of 41.43% from the […]
TD Cowen Issues Pessimistic Forecast for Jazz Pharmaceuticals (NASDAQ:JAZZ) Stock Price
Jazz Pharmaceuticals (NASDAQ:JAZZ – Free Report) had its target price lowered by TD Cowen from $200.00 to $195.00 in a research note issued to investors on Thursday morning,Benzinga reports. The firm currently has a buy rating on the specialty pharmaceutical company’s stock. Other equities research analysts also recently issued reports about the stock. HC Wainwright […]
last updated on 14 Nov 21:15